Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
Phase 3
Recruiting
- Conditions
- House Dust Mite Allergy
- First Posted Date
- 2022-05-27
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Probelte Pharma S.L.U.
- Target Recruit Count
- 350
- Registration Number
- NCT05395689
- Locations
- 🇪🇸
Hospital Vega Baja, Orihuela, Alicante, Spain
🇪🇸Hospital General de Granollers, Granollers, Barcelona, Spain
🇪🇸Hospital de Canarias, Santa Cruz De Tenerife, Canarias, Spain
Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander
Completed
- Conditions
- Rhinoconjunctivitis With or Without Allergic Asthma
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Probelte Pharma S.L.U.
- Target Recruit Count
- 34
- Registration Number
- NCT04207697
- Locations
- 🇪🇸
Campus de la Salud University Hospital, Granada, Andalucía, Spain
🇪🇸Ciudad de Jaen Hospital, Jaén, Andalucía, Spain
🇪🇸Quirón Campo de Gibraltar Hospital, Palmones, Cádiz, Spain
Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata
Completed
- Conditions
- Rhinoconjunctivitis With or Without Allergic Asthma
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Probelte Pharma S.L.U.
- Target Recruit Count
- 65
- Registration Number
- NCT03604718
- Locations
- 🇪🇸
Universitary Hospital of Vic, Vic, Barcelona, Spain
🇪🇸Medical Center Fedear, Barcelona, Cataluña, Spain
🇪🇸University Hospital of Torrejon, Torrejón De Ardoz, Madrid, Spain
News
No news found